Table 2.
Lifetime and 1-month prevalence of substance use among substance-dependent women and comparison group.
| Substance dependent group (n = 41) | Comparison group (n = 47) | Statistical comparison OR (95% CI) | ||
|---|---|---|---|---|
| ALCOHOL | % Ever used | 95.0 | 97.9 | not significant |
| % Used last month | 22.5 | 48.9 | 0.30 (0.12–0.77)* | |
| Mean days used month (SD) | 3.4 (2.9) | 3.9 (2.3) | not significant | |
|
| ||||
| NICOTINE | % Ever used | 97.6 | 74.5 | 13.70 (1.70–111.11)* |
| % Used last month | 78.0 | 4.3 | 80.0 (16.19–395.37)** | |
| Mean days used month (SD) | 27.9 (6.8) | 20.0 (14.1) | not significant | |
|
| ||||
| CANNABIS | % Ever used | 95.1 | 83.0 | not significant |
| % Used last month | 34.1 | 0.0 | N/A | |
| Mean days used month (SD) | 18.2 (12.6) | 0 | N/A | |
|
| ||||
| HEROIN | % Ever used | 75.6 | 4.3 | 71.43 (14.29–333.33)** |
| % Used last month | 17.1 | 0.0 | N/A | |
| Mean days used month (SD) | 5.3 (6.9) | 0 | N/A | |
| % Ever injected | 56.1 | 0.0 | N/A | |
| % Injected last month | 12.2 | 0.0 | N/A | |
|
| ||||
| AMPHETAMINE | % Ever used | 80.0 | 46.8 | 4.55 (1.73–11.90)* |
| % Used last month | 2.5 | 0.0 | N/A | |
| Mean days used month (SD) | 2.0 (0.3) | 0 | N/A | |
| % Ever injected | 47.5 | 0.0 | N/A | |
| % Injected last month | 0.0 | 0.0 | N/A | |
|
| ||||
| COCAINE | % Ever used | 68.3 | 40.4 | 3.17 (1.32–7.63)* |
| % Used last month | 4.9 | 0.0 | N/A | |
| Mean days used month (SD) | 1.5 (0.7) | 0 | N/A | |
| % Ever injected | 41.5 | 0.0 | N/A | |
| % Injected last month | 0.0 | 0.0 | N/A | |
|
| ||||
| BENZODIAZEPINE | % Ever used | 75.6 | 14.9 | 17.86 (6.06–52.63)** |
| % Used last month | 12.2 | 0.0 | N/A | |
| Mean days used month (SD) | 13.6 (15.0) | 0 | N/A | |
| % Ever injected | 7.3 | 0.0 | N/A | |
| % Injected last month | 0.0 | 0.0 | N/A | |
*P < .05.
**P < .001.